Parabens have been used as preservatives in foods, injectables, and topical preparations for nearly 10 decades. Present in nature, rapidly metabolized by skin and liver enzymes, they have an excellent safety record. However, in the past 15 years, they have been under scrutiny for their alleged estrogenic and antiandrogenic effects, as well as their putative role in promoting cancerogenesis through endocrine disruption. Scientific articles supporting these assertions have led the European Community to ban or restrict the use of some parabens. Despite that methylparaben and ethylparaben have negligible endocrine disruption activity, the food, pharmaceutical, and cosmetic industries are under pressure from scare campaigns in the media and are responding by replacing parabens with other biocides that cause multiple cases, and even worldwide epidemics, of allergic contact sensitization. In the present review, we present a balanced account of the published literature about the metabolism and potential toxicology of parabens.
Get full access to this article
View all access options for this article.
References
1.
KangYH, ParkerCC, SmithAC, et al.Characterization and distribution of phenolics in carrot cell walls. J Agric Food Chem, 2008; 56 (18): 8558–8564.
2.
SellappanS, AkohCC, KrewerG. Phenolic compounds and antioxidant capacity of Georgia-grown blueberries and blackberries. J Agric Food Chem, 2002; 50 (8): 2432–2438.
3.
CashmanAL, WarshawEM. Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties. Dermatitis, 2005; 16 (2): 57–66.
4.
Cosmetic Ingredient Review Expert Panel. Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products. Int J Toxicol, 2008; 27 (suppl 4): 1–82.
5.
CastelainF, CastelainM. Parabens: a real hazard or a scare story?. Eur J Dermatol, 2012; 22 (6): 723–727.
6.
BonnevieP. Øverfolsomhed for aetylparaoxybenzoat (Mycocten). Nord Med, 1940; 6: 684–685.
7.
JongCT, StathamBN, GreenCM, et al.Contact sensitivity to preservatives in the UK, 2004–2005: results of multicentre study. Contact Dermatitis, 2007; 57 (3): 165–168.
8.
WilkinsonJD, ShawS, AndersenKE, et al.Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991–2000). Contact Dermatitis, 2002; 46: 207–210.
9.
SvedmanC, AndersenKE, BrandãoFM, et al.Follow-up of the monitored levels of preservative sensitivity in Europe: overview of the years 2001–2008. Contact Dermatitis, 2012; 67: 312–314.
10.
WarshawEM, BelsitoDV, TaylorJS, et al.North American Contact Dermatitis Group patch test results: 2011–2012. Dermatitis, 2015; 26 (1): 49–59.
11.
GonçaloM, GoossensA. Whilst Rome burns: the epidemic of contact allergy to methylisothiazolinone. Contact Dermatitis, 2013; 68: 257–258.
KarpuzogluE, HolladaySD, GogalRMJr. Parabens: potential impact of low-affinity estrogen receptor binding chemicals on human health. J Toxicol Environ Health B Crit Rev, 2013; 16 (5): 321–335.
15.
KirchhofMG, de GannesGC. The health controversies of parabens. Skin Therapy Lett, 2013; 18 (2): 5–7.
16.
RoutledgeEJ, ParkerJ, OdumJ, et al.Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol, 1998; 153: 12–19.
17.
HossainiA, LarsenJJ, LarsenJC. Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food Chem Toxicol, 2000; 38 (4): 319–323.
18.
ByfordJR, ShawLE, DrewMG, et al.Oestrogenic activity of parabens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol, 2002; 80 (1): 49–60.
19.
DarbrePD, ByfordJR, ShawLE, et al.Oestrogenic activity of isobutylparaben in vitro and in vivo. J Appl Toxicol, 2002; 22: 219–226.
20.
DarbrePD, ByfordJR, ShawLE, et al.Oestrogenic activity of benzylparaben. J Appl Toxicol, 2003; 23: 43–51.
21.
DarbrePD. Underarm cosmetics and breast cancer. J Appl Toxicol, 2003; 2 (2): 89–95.
22.
RagethCJ. One step forward in proving, that underarm cosmetics do not cause breast cancer. Breast, 2005; 14: 85–86.
23.
DarbrePD. Underarm antiperspirants/deodorants and breast cancer. Breast Cancer Res, 2009; 11 (suppl 3): S5.
24.
DarbrePD, AljarrahA, MillerWR, et al.Concentrations of parabens in human breast tumours. J Appl Toxicol, 2004; 24 (1): 5–13.
25.
HarveyPW, EverettDJ. Significance of the detection of esters of p-hydroxybenzoic acid (parabens) in human breast tumours. J Appl Toxicol, 2004; 24: 1–4.
26.
GoldenR, GandyJ. Comment on the publication by Darbre et al. (2004). J Appl Toxicol, 2004; 24 (4): 297–299.
27.
JeffreyAM, WilliamsGM. The paper by Darbre et al. (2004) reports the measurement of parabens in 20 human breast tumors. J Appl Toxicol, 2004; 24 (4): 301–303.
28.
FlowerC. Observations on the paper by Darbre et al. (2204). J Appl Toxicol, 2004; 24 (4): 304–305.
29.
DarbrePD, PopeGS, AljarrahA, et al.Reply to Robert Golden and Jay Gandy. J Appl Toxicol, 2004; 24 (4): 299–301.
30.
DarbrePD, HarveyPW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol, 2008; 28: 561–578.
31.
LeminiC, JaimezR, AvilaME, et al.In vivo and in vitro estrogen bioactivities of alkyl parabens. Toxicol Ind Health, 2003; 19: 69–79.
32.
OishiS. Lack of spermatotoxic effects of methyl and ethyl esters of p-hydroxybenzoic acid in rats. Food Chem Toxicol, 2004; 42: 1845–1849.
33.
PrusakiewiczJJ, HarvilleHM, ZhangY, et al.Parabens inhibit human skin estrogen sulfotransferase activity: possible link to paraben estrogenic effects. Toxicology, 2007; 232: 248–256.
34.
CharlesAK, DarbrePD. Combinations of parabens at concentrations measured in human breast tissue can increase proliferation of MCF-7 human breast cancer cells. J Appl Toxicol, 2013; 33: 390–398.
35.
MirickDK, DavisS, ThomasDB. Antiperspirant use and the risk of breast cancer. J Natl Cancer Inst, 2002; 94: 1578–1580.
36.
McGrathKG. An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev, 2003; 12: 479–485.
37.
YeX, KuklenyikZ, BishopAM, et al.Quantification of the urinary concentrations of parabens in humans by on-line solid phase extraction-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 2006; 844: 53–59.
38.
IshiwatariS, SuzukiT, HitomiT, et al.Effects of methyl paraben on skin keratinocytes. J Appl Toxicol, 2007; 27: 1–9.
39.
JanjuaNR, MortensenGK, AnderssonAM, et al.Systemic uptake of diethyl phthalate, dibutyl phthalate, and butyl paraben following whole-body topical application and reproductive and thyroid hormone levels in humans. Environ Sci Technol, 2007; 41: 5564–5570.
40.
FrederiksenH, JørgensenN, AnderssonAM. Parabens in urine, serum and seminal plasma from healthy Danish men determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). J Expo Sci Environ Epidemiol, 2011; 21 (3): 262–271.
41.
SandangerTM, HuberS, MoeMK, et al.Plasma concentrations of parabens in postmenopausal women and self-reported use of personal care products: the NOWAC postgenome study. J Expo Sci Environ Epidemiol, 2011; 21 (6): 595–600.
42.
OishiS. Effects of butylparaben on the male reproductive system in rats. Toxicol Ind Health, 2001; 17 (1): 31–39.
43.
OishiS. Effects of butyl paraben on the male reproductive system in mice. Arch Toxicol, 2002; 76 (7): 423–429.
44.
OishiS. Effects of propyl paraben on the male reproductive system. Food Chem Toxicol, 2002; 40 (12): 1807–1813.
45.
HobermanAM, SchreurDK, LeazerT, et al.Lack of effect of butylparaben and methylparaben on the reproductive system in male rats. Birth Defects Res B Dev Reprod Toxicol, 2008; 83: 123–133.
46.
ShawJ, deCatanzaroD. Estrogenicity of parabens revisited: impact of parabens on early pregnancy and an uterotrophic assay in mice. Reprod Toxicol, 2009; 28 (1): 26–31.
47.
DastonGP. Developmental toxicity evaluation of butylparaben in Sprague-Dawley rats. Birth Defects Res B Dev Reprod Toxicol, 2004; 71 (4): 296–302.
48.
GazinV, MarsdenE, MargueriteF. Oral propylparaben administration to juvenile male Wistar rats did not induce toxicity in reproductive organs. Toxicol Sci, 2013; 136 (2): 392–401.
49.
GoldenR, GandyJ, VollmerG. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit Rev Toxicol, 2005; 35 (5): 435–458.
50.
WitorschRJ, ThomasJA. Personal care products and endocrine disruption: a critical review of the literature. Crit Rev Toxicol, 2010; 40 (suppl 3): 1–30.
51.
ScialliAR. Reproductive effects of the parabens. Reprod Toxicol, 2011; 32 (1): 138–140.
52.
HuP, ChenX, WhitenerRJ, et al.Effects of parabens on adipocyte differentiation. Toxicol Sci, 2013; 131 (1): 56–70.
53.
MeekerJD, YangT, YeX, et al.Urinary concentrations of parabens and serum hormone levels, semen quality parameters, and sperm DNA damage. Environ Health Perspect, 2011; 119 (2): 252–257.
54.
KangS, KimS, ParkJ, et al.Urinary paraben concentrations among pregnant women and their matching newborn infants of Korea, and the association with oxidative stress biomarkers. Sci Total Environ, 2013; 461–462: 214–221.
55.
WatkinsDJ, FergusonKK, Anzalota Del ToroLV, et al.Associations between urinary phenol and paraben concentrations and markers of oxidative stress and inflammation among pregnant women in Puerto Rico. Int J Hyg Environ Health, 2015; 218 (2): 212–219.
56.
SoniMG, CarabinIG, BurdockGA. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol, 2005; 43 (7): 985–1015.
